CONSUMER HEALTHCARE: COVID-19 IMPACTS AND OBSERVATIONS
By IRI and Kline
The unprecedented crisis of the coronavirus (COVID-19) outbreak, which began in March 2020, has affected the U.S. population in profound ways that seem to change daily. With shelter-in-place orders, schools, colleges, restaurants, lodging establishments, office buildings, some industrial facilities, recreational facilities, and many non-essential government facilities closed, and a unique recessionary/boon economy (for some) ensued. Much of this patchwork mixture of experiences continues as the U.S. experiences a resurgence of the virus.
How has this impacted consumer healthcare practices and product sales patterns? What will the future bring? In this short paper, we assess the possible impact on the consumer healthcare market, a space with which both Kline and IRI are deeply familiar, having tracked the industry for decades. We’ve looked at the impacts of COVID-19 on the consumer healthcare market, defined as nonprescription or OTC drugs, dietary supplements, and devices used by consumers to manage their health.
Download the Full Report
95% of CPG, retail, and health and beauty companies in the Fortune 100 work with us.